This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Xiaocheng Jiang in Microfluidic Cell Isolation
Introduction
Xiaocheng Jiang is an accomplished inventor based in Stoneham, MA (US). He has made significant contributions to the field of microfluidics, particularly in the isolation of cells associated with platelets. His innovative work has the potential to advance medical diagnostics and treatment methodologies.
Latest Patents
Xiaocheng Jiang holds a patent for a groundbreaking method titled "Platelet-targeted microfluidic isolation of cells." This patent describes methods and systems for isolating platelet-associated nucleated target cells, such as circulating epithelial cells, circulating tumor cells (CTCs), circulating endothelial cells (CECs), circulating stem cells (CSCs), neutrophils, and macrophages from biological fluids like blood and bone marrow. The process involves obtaining a cell capture chamber with binding moieties that specifically bind to platelets, allowing for the effective isolation of target cells.
Career Highlights
Xiaocheng Jiang is currently associated with The General Hospital Corporation, where he applies his expertise in microfluidics to enhance medical research and patient care. His innovative approaches have garnered attention in the scientific community, contributing to advancements in cell isolation techniques.
Collaborations
Xiaocheng has collaborated with notable professionals in his field, including Mehmet Toner and Shannon Stott. These collaborations have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Xiaocheng Jiang's work in microfluidic cell isolation exemplifies the intersection of innovation and healthcare. His contributions are paving the way for improved diagnostic techniques and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
